1Burger RA, Sill MW, Monk B J, et al. Phase Ⅱ trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group study[ J ]. J Clin Oncol, 2007,25: 5165-5171.
2Markman M, Liu PY, Wilczynski S, et al. Phase Ⅲ randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial[J]. J Clin Oncol, 2003, 21 : 2460-2465.
3Pfisterer J, Plante M, Vergote I, et al. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an Intergroup Trial of the AGOOVAR, the NCIC CTG, and the EORTC GCG[J]. J Clin Oncol, 2006,6:913-918.
4Sorbe B. Swedish-Norwegian Ovarian Cancer Study Group: consolidation treatment of advanced (FIGO) stage ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy,chmotherapy, and no further treatment [J ]. Int J Gynecol Cancer, 2003,13 ( 3 ) : 278 -286.
5Thomas GM. Is there a role for consolidation or salvage radiotherapy after chemotherapy in advanced epithelial ovarian cancer? [ J ]. Gynecol Oncol, 1993,51:97-103.
